Home »
KBroVet® (potassium bromide chewable tablets) has received full approval from the FDA for the control of seizures associated with idiopathic epilepsy (IE) in dogs.
Ashley Galkin, CVT, of VEG ER for Pets in Warwick, Rhode Island, has been honored with the PRN® Pharmacal Veterinary Technician Award.
Cassidi Hoffman of Mountain Veterinary Hospital in Bellingham, WA, has been named the first winner of the PRN® Pharmacal Veterinary Technician Award.
PRN Pharmacal announces a new annual Veterinary Technician Awards Program to recognize credentialed vet techs for their dedication, compassion, and clinical expertise. Winners receive $500 awards to support education and career growth.
First-in-class oral management option for hypertrophic cardiomyopathy (HCM) earns FDA conditional approval, changing the landscape of feline medicine
New dental device provides an advanced, yet simple, option for the filling and augmentation of bony and periodontal defects in dogs.
The strategic combination brings leading-edge product Felycin®-CA1 (Sirolimus Delayed-Release Tablets) and innovative pipeline together with PRN® Pharmacal leading expertise in commercializing new therapies for chronic pet health conditions Shawnee, Kansas, May 5,...
PRN® Pharmacal is marking National Epilepsy Awareness Month by offering one free neurology consult with Web Vet Seizure Specialists for every two bottles of KBroVet®-CA1 180 count bottles purchased during November and December.
CoproBan® Soft Chews are now available in a 40-count jar featuring updated consumer-friendly packaging and improved pet acceptance, helping make canine coprophagia (the eating of feces) easier to control.
The U.S. Food and Drug Administration (FDA) has approved Firocoxib Tablets for Dogs. To be marketed under the brand name Sē•Qual™, Firocoxib Chewable Tablets for Dogs joins Firocoxib Tablets for Horses as the second generic nonsteroidal anti-inflammatory drug (NSAID)...